Pharmaceuticals

Subcutaneous Drug Delivery Devices Market Insights: In-Depth Look at Growth Trends, Market Size, and Opportunities for 2025-2034

June 20, 2025 by Marketing Posting

Discover trends, market shifts, and competitive outlooks for the subcutaneous drug delivery devices industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#What Are the Key Projections for the CAGR of the Subcutaneous Drug Delivery Devices Market Size From 2025 to 2034?#_x000D_

In recent times, the market size for subcutaneous drug delivery devices has seen robust growth. The market, which is set to expand from $27.66 billion in 2024 to approximately $29.77 billion in 2025, is expected to experience a Compound Annual Growth Rate (CAGR) of 7.6%. This significant growth within the historic period is linked to several factors. These include the rising incidence of chronic diseases, a growing need for personal drug administration, increases in rates of diabetes and obesity, a preference among patients for convenient treatments, and a surge in the senior population._x000D_

_x000D_

In the subsequent years, we can anticipate a robust expansion in the market for subcutaneous drug delivery devices. The market is projected to amplify to $39.57 billion in 2029, recording a compound annual growth rate (CAGR) of 7.4%. This progression during the forecasted era is due to factors such as the enlargement in the biologics and biosimilars market, increased utilization of wearable drug delivery systems, the spread of individualized treatment approaches, enhancements in healthcare recompense guidelines, as well as an upsurge in focus on home healthcare. Prominent tendencies in the projected period encompass the incorporation of digital health innovations, the evolution of smart and interconnected apparatuses, the escalation in minimally invasive procedures, progression in needle-free injection mechanisms, coupled with the advent of artificial intelligence in device invention._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=19723&type=smp_x000D_

_x000D_

#What Are the Core Market Drivers Propelling Growth in the Subcutaneous Drug Delivery Devices Industry?#_x000D_

The escalating occurrence of diabetes and cardiovascular diseases (CVD) is anticipated to bolster the expansion of the subcutaneous drug delivery devices market. The surge in these conditions can be attributed to aging populations, poor diets, lack of physical activity, obesity, socioeconomic disparities, stress, environmental influences, and inadequate access to preventative healthcare. Subcutaneous drug delivery devices serve a crucial role in the administration of insulin and other vital medications for maintaining blood sugar levels and in managing cardiovascular diseases through the provision of drugs such as anticoagulants or lipid-lowering agents, presenting a controlled and easy method to handle these chronic diseases. For example, in April 2023, data from the British Diabetic Association, a charity dedicated to those with diabetes, revealed that 4.3 million people in the UK have been diagnosed with the disease. There has been an increase of 148,951 registered cases in 2021-22 as compared to the previous year, with over 2.4 million individuals at high risk of developing type 2 diabetes in the UK. Furthermore, data from the Centers for Disease Control and Prevention, in May 2024, disclosed that in 2022, heart disease was responsible for the deaths of 702,880 individuals, representing 1 out of every 5 deaths. Hence, the rising occurrence of diabetes and cardiovascular diseases (CVD) is fuelling the growth of the subcutaneous drug delivery devices market._x000D_

_x000D_

#What Segment Types Define the Subcutaneous Drug Delivery Devices Market Structure?#_x000D_

The subcutaneous drug delivery devicesmarket covered in this report is segmented –_x000D_

_x000D_

1) By Product Type: Insulin Pens, Pen Needles, Injector Pens, Auto-Injectors, Implantable Pumps_x000D_

2) By Application: Diabetes, Fertility, Oncology_x000D_

3) By End-User: Hospitals And Clinics, Homecare Settings, Ambulatory Surgical Centers_x000D_

_x000D_

Subsegments:_x000D_

1) Insulin Pens: Disposable Insulin Pens, Reusable Insulin Pens_x000D_

2) Pen Needles: Standard Pen Needles, Safety Pen Needles_x000D_

3) Injector Pens: Disposable Injector Pens, Reusable Injector Pens_x000D_

4) Auto-Injectors: Manual Auto-Injectors, Smart Auto-Injectors_x000D_

5) Implantable Pumps: Insulin Pumps, Drug Infusion Pumps_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=19723&type=smp_x000D_

_x000D_

#Which Regions Are Driving the Next Phase of the Subcutaneous Drug Delivery Devices Market Growth?#_x000D_

North America was the largest region in the subcutaneous drug delivery devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the market going forward. The regions covered in the subcutaneous drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#What Are the Strategic Trends Steering the Subcutaneous Drug Delivery Devices Market Direction?#_x000D_

Leading firms in the subcutaneous drug delivery devices market are prioritizing the creation of novel products like miniature digital liquid flow sensors. The aim is to improve the accuracy and safety of subcutaneous drug delivery through precise, adaptable flow sensors designed for large-volume injectors. These compact devices are engineered to accurately gauge the flow rate of liquids in small-scale applications, supplying digital feedback for reliable monitoring and control. For instance, Sensirion AG, a Swiss company offering environmental and flow sensors, unveiled the SLD3x series sensor platform in May 2024. This series encompasses highly precise digital liquid flow sensors that can be tailored to specific needs, enabling precise flow measurement, occlusion detection, in-line air bubble spotting, and liquid temperature monitoring. These miniaturized sensors are perfect for mass-scale medical device production, promising optimum dosing and improved patient safety in subcutaneous drug delivery._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/subcutaneous-drug-delivery-devices-global-market-report_x000D_

_x000D_

#What Is the Definition of the Subcutaneous Drug Delivery Devices Market?#_x000D_

Subcutaneous drug delivery devices are medical devices designed to administer medications directly into the subcutaneous tissue, the layer of fat and connective tissue just beneath the skin. These devices are used for the delivery of various drugs, including insulin, hormones, and biologics, providing a convenient and minimally invasive method of drug administration._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19723_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 3156230293_x000D_

Asia +44 2071930708_x000D_

Europe +44 2071930708_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_